IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland
Open accessThe DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.
Abstract
High serum levels of IL-6 correlate with poor outcome in breast cancer patients. However, no data are available on the relationship between IL-6 and mammary stem/progenitor cells, which may fuel the genesis of breast cancer in vivo. Herein, we address this issue in the MCF-7 breast cancer cell line and in primary human mammospheres (MS), multicellular structures enriched in stem/progenitor cells of the mammary gland. MS from node invasive breast carcinoma tissues expressed IL-6 mRNA at higher levels than did MS from matched non-neoplastic mammary glands. In addition, IL-6 mRNA was detected only in basal-like breast carcinoma tissues, an aggressive breast carcinoma variant showing stem cell features. IL-6 treatment triggered Notch-3-dependent upregulation of the Notch ligand Jagged-1 and promotion of MS and MCF-7-derived spheroid growth. Moreover, IL-6 induced Notch-3-dependent upregulation of the carbonic anhydrase IX gene and promoted a hypoxia-resistant/invasive phenotype in MCF-7 cells and MS. Finally, autocrine IL-6 signaling relied upon Notch-3 activity to sustain the aggressive features of MCF-7-derived hypoxia-selected cells. In conclusion, these data support the hypothesis that IL-6 induces malignant features in Notch-3-expressing stem/progenitor cells from human ductal breast carcinoma and normal mammary gland.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“IL-6 is an MSC-secreted inflammatory cytokine displaying pro-survival, pro-growth and pro-angiogenic activities [11], which has been implicated in tumor progression of various cancers including breast cancer [113, 114].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [114]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
World Health Organization Classification of Tumours
Fletcher, C., van den Berg, A., & Molenaar, I. (2002) · Cited by 7,079
ELSTON, C. W., & ELLIS, I. O. (1991) · Histopathology · doi:10.1111/j.1365-2559.1991.tb00229.x · Cited by 6,175
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
O’Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007) · Nature · doi:10.1038/nature05372 · Cited by 4,087
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,339
Nielsen, T. O., Hsu, F. D., Jensen, K., Cheang, M., Karaca, G., Hu, Z., Hernandez-Boussard, T., Livasy, C., Cowan, D., Dressler, L., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0220 · Cited by 2,663
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M. J., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,406
Research works printed but not linked: 4
- Zhang, 1999, Anticancer Res., 19, 1427
- Sehgal, 1991, EXS., 59, 178
- Conze, 2001, Cancer Res., 61, 8851
- Trikha, 2003, Clin. Cancer Res., 9, 4653
Cited by
Items 401–500 of 839
Loss of annexin A1 disrupts normal prostate glandular structure by inducing autocrine IL-6 signaling
Inokuchi, J., Lau, A., Tyson, D. R., & Ornstein, D. K. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp078 · Cited by 43
GP130 Cytokines in Breast Cancer and Bone
Omokehinde, T., & Johnson, R. W. (2020) · Cancers · doi:10.3390/cancers12020326 · Cited by 43
Chen, J., Li, X., Huang, C., Lin, Y. H., & Dai, Q.-F. (2020) · Technology in Cancer Research & Treatment · doi:10.1177/1533033820951807 · Cited by 43
Shao, N., Chen, L., Ye, R.-Y., Lin, Y., & Wang, S. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.01.022 · Cited by 43
Bone marrow-derived myofibroblasts promote colon tumorigenesis through the IL-6/JAK2/STAT3 pathway
Zhu, L., Cheng, X., Ding, Y., Shi, J., Jin, H., Wang, H., Wu, Y., Ye, J., Lu, Y., Wang, T. C., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.09.017 · Cited by 43
Repression of mammary adipogenesis by genistein limits mammosphere formation of human MCF-7 cells
Montales, M. T. E., Rahal, O. M., Nakatani, H., Matsuda, T., & Simmen, R. C. M. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0520 · Cited by 43
FOXA1 is Prognostic of Triple Negative Breast Cancers by Transcriptionally Suppressing SOD2 and IL6
Dai, X., Cheng, H., Chen, X., Li, T., Zhang, J., Jin, G., Cai, D., & Huang, Z. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.31009 · Cited by 44
Nengroo, M. A., Verma, A., & Datta, D. B. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155916 · Cited by 42
CGI-99 promotes breast cancer metastasis via autocrine interleukin-6 signaling
Lin, C., Liao, W., Jian, Y., Peng, Y., Zhang, X., Ye, L., Cui, Y.-L., Wang, B., Wu, X., Xiong, Z., et al. (2017) · Oncogene · doi:10.1038/onc.2016.525 · Cited by 42
Goyal, P., Brünnert, D., Ehrhardt, J., Bredow, M., Piccenini, S., & Zygmunt, M. (2013) · Molecular Human Reproduction · doi:10.1093/molehr/gat023 · Cited by 41
Choi, C.-W., Tran, N. T. T., Ngu, T. V., Park, S. W., Song, M. S., Kim, S. H., Bae, Y., Diskul‐Na‐Ayudthaya, P., Munir, J., Kim, E., et al. (2018) · Oncogenesis · doi:10.1038/s41389-018-0094-y · Cited by 41
Haider, M., Ridlmaier, N., Smit, D. J., & Taipaleenmäki, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062898 · Cited by 41
GATA1-regulated JAG1 promotes ovarian cancer progression by activating Notch signal pathway
Liu, Z., Zhu, Y., Li, F., & Xie, Y. (2020) · PROTOPLASMA · doi:10.1007/s00709-019-01477-w · Cited by 40
Kim, H. J., Hwang, S.-H., Han, M., Baek, S., Sim, H.-E., Yoon, S., Baek, S., Kim, B.-S., Kim, J., Kim, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039482 · Cited by 40
Mirkeshavarz, M., Ganjibakhsh, M., Aminishakib, P., Farzaneh, P., Mahdavi, N., Vakhshiteh, F., Karimi, M. A., Gohari, N. S., Kamali, F., Kharazifard, M. J., et al. (2017) · Cellular and Molecular Biology · doi:10.14715/cmb/2017.63.10.21 · Cited by 40
Pim-3 enhances melanoma cell migration and invasion by promoting STAT3 phosphorylation
Liu, J., Qu, X., Shao, L., Hu, Y., Yu, X., Lan, P., Guo, Q., Han, Q., Zhang, J., & Zhang, C. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2017.1414756 · Cited by 40
Effects of surgery on the cancer stem cell niche
O’Leary, D., O'Leary, E., Foley, N., Cotter, T. G., Wang, J. H., & Redmond, H. P. (2016) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2015.12.008 · Cited by 37
Moderate hyperthermic heating encountered during thermal ablation increases tumor cell activity
Markezana, A., Ahmed, M., Kumar, G., Zorde‐Khvalevsky, E., Rozenblum, N., Galun, E., & Goldberg, S. N. (2020) · International Journal of Hyperthermia · doi:10.1080/02656736.2020.1714084 · Cited by 37
Notch1/2/3/4 are prognostic biomarker and correlated with immune infiltrates in gastric cancer
Hu, J. M., Yu, J., Gan, J., Song, N., Shi, L., Liu, J., Zhang, Z., & Du, J. (2020) · Aging · doi:10.18632/aging.102764 · Cited by 37
Notch Signaling Pathway and Endocrine Resistance in Breast Cancer
Bai, J., Wei, M., Li, J., & Zhang, G. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00924 · Cited by 37
Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma
Bennani-Baïti, I. M., Aryee, D. N. T., Ban, J., Machado, I., Kauer, M. O., Muehlbacher, K., Amann, G., Llombart‐Bosch, A., & Kovar, H. (2011) · The Journal of Pathology · doi:10.1002/path.2966 · Cited by 37
Jiang, Y., Yan, H. Q., Huang, X. B., Wang, Y. N., Li, Q., & GAO, F. G. (2015) · Oncotarget · doi:10.18632/oncotarget.5825 · Cited by 37
Bhat, V., Allan, A. L., & Raouf, A. (2019) · Cancers · doi:10.3390/cancers11091240 · Cited by 36
Breast Cancer and Cancer Stem Cells: A Mini-Review
Filipová, A., Seifrtová, M., Mokrý, J., Dvořák, J., Řezáčová, M., Filip, S., & Garcia, D. D. (2014) · Tumori Journal · doi:10.1177/1636.17886 · Cited by 36
Nuclear JAK2: Form and Function in Cancer
Qian, C., Yao, J., & Si, J. (2011) · The Anatomical Record · doi:10.1002/ar.21443 · Cited by 36
Endothelial cell-derived interleukin-6 regulates tumor growth
Neiva, K. G., Warner, K. A., Campos, M. S., Zhang, Z., Moren, J., Danciu, T., & Nor, J. E. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-99 · Cited by 36
Monticone, M., Biollo, E., Fabiano, A., Fabbi, M., Daga, A., Romeo, F., Maffei, M., Melotti, A., Giaretti, W., Corte, G., et al. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0225 · Cited by 36
Lin, X., Yang, L., Wang, G., Zi, F., Yan, H., Guo, X., Chen, J., Chen, Q., Huang, X., Li, Y., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21611 · Cited by 36
Defects in Innate Immunity Render Breast Cancer Initiating Cells Permissive to Oncolytic Adenovirus
Ahtiainen, L., Mirantes, C., Jahkola, T., Escutenaire, S., Diaconu, I., Österlund, P., Kanerva, A., Cerullo, V., & Hemminki, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013859 · Cited by 36
Prognostic value of ZFP36 and SOCS3 expressions in human prostate cancer
Zhu, J., Yuan, D., Wenwen, C. H. E. N., Han, Z.-D., Liang, Y.-X., Chen, G., Fu, X., Liang, Y., Chen, G.-X., Sun, Z., et al. (2015) · Clinical & Translational Oncology · doi:10.1007/s12094-015-1432-6 · Cited by 35
Thomas, E. B., Thankan, R. S., Purushottamachar, P., Huang, W., Kane, M. A., Zhang, Y., Ambulos, N. P., Weber, D. J., & Njar, V. C. O. (2022) · Molecular Carcinogenesis · doi:10.1002/mc.23406 · Cited by 35
Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review
Koyande, N. P., Srivastava, R., Padmakumar, A., & Rengan, A. K. (2022) · Vaccines · doi:10.3390/vaccines10101727 · Cited by 35
Mechanistic insights of adipocyte metabolism in regulating breast cancer progression
Zhang, F., & Liu, S. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104741 · Cited by 35
STAT3 gene polymorphisms and susceptibility to non-small cell lung cancer
Jiang, B., Zhu, Z. Z., Liu, F., Yang, L., Zhang, W. Y., Yuan, H. H., Wang, J., Hu, X., & Huang, G. (2011) · Genetics and Molecular Research · doi:10.4238/vol10-3gmr1071 · Cited by 34
Zhao, S., Ohara, S., Kanno, Y., Midorikawa, Y., Nakayama, M., Makimura, M., Park, Y., & Inouye, Y. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.021 · Cited by 34
Lü, J., Xu, B., Xue, Z., Xie, J., Zheng, C., Huang, C., & Li, P. (2020) · Cancer Medicine · doi:10.1002/cam4.3514 · Cited by 34
MCM10 compensates for Myc‐induced DNA replication stress in breast cancer stem‐like cells
Murayama, T., Takeuchi, Y., Yamawaki, K., Natsume, T., Li, M., Marcela, R. N., Nishimura, T., Kogure, Y., Nakata, A., Tominaga, K., et al. (2020) · Cancer Science · doi:10.1111/cas.14776 · Cited by 34
Breast Cancer Stem Cells and the Immune System: Promotion, Evasion and Therapy
Boyle, S. T., & Kochetkova, M. (2014) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-014-9323-y · Cited by 34
Therapeutic Targeting of Cancer Stem Cells
Maugeri‐Saccà, M., Zeuner, A., & Maria, R. D. (2011) · Frontiers in Oncology · doi:10.3389/fonc.2011.00010 · Cited by 35
Chang, K., Huang, C., Hsu, T., Hsu, C.-C., Liu, J.-J., Chuang, C., Hung, J., Chang, W., Tsai, K. K., & Chuang, J. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.09.095 · Cited by 34
Caveolin‐1 in oncogenic metabolic symbiosis
Raudenská, M., Gumulec, J., Balvan, J., & Masařík, M. (2020) · International Journal of Cancer · doi:10.1002/ijc.32987 · Cited by 33
Liu, A., Liu, Y., Jin, Z., Hu, Q., Li, L., Jou, D., Yang, J., Xu, Z., Wang, H., Li, C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046624 · Cited by 33
Bhattacharya, S. D., Mi, Z., Talbot, L. J., Guo, H., & Kuo, P. C. (2012) · Surgery · doi:10.1016/j.surg.2012.06.011 · Cited by 33
Liu, A., Liu, Y., Xu, Z., Yu, W., Wang, H., Li, C., & Lin, J. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01932.x · Cited by 33
Huang, W., Hung, C., Wei, C., Chen, T.-M., Chien, P., Pan, H., Lin, Y.-M., & Chen, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.11471 · Cited by 33
Arnold, K. M., Opdenaker, L. M., Flynn, N. J., Appeah, D. K., & Sims‐Mourtada, J. (2020) · International Journal of Radiation Biology · doi:10.1080/09553002.2020.1705423 · Cited by 33
The MHC Class II Immunopeptidome of Lymph Nodes in Health and in Chemically Induced Colitis
Fugmann, T., Şofron, A., Ritz, D., Bootz, F., & Neri, D. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1601157 · Cited by 32
Rajski, M., Vogel, B., Baty, F., Rochlitz, C. F., & Buess, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029743 · Cited by 32
Liao, W., Liaw, C., Huang, Y., Han, H.-Y., Hsu, H.-W., Hwang, S., Kuo, S., & Shen, C. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/170261 · Cited by 32
Integrin-linked kinase as a novel molecular switch of the IL-6-NF-κB signaling loop in breast cancer
Hsu, E., Kulp, S. K., Huang, H.-L., Tu, H., Chao, M., Tseng, Y., Yang, M.-C., Salunke, S. B., Sullivan, N. J., Chen, W.-C., et al. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw020 · Cited by 32
Maguire, G. (2019) · PubMed Central · Cited by 31
Strapcova, S., Takáčová, M., Csáderová, L., Martinelli, P., Lukáčiková, Ľ., Gál, V., Kopáček, J., & Švastová, E. (2020) · Cancers · doi:10.3390/cancers12082005 · Cited by 31
Tian, T., Xie, X., Yi, W., Zhou, Y., Xu, Y., Wang, Z., Zhang, J., Lin, M., Zhang, R., Lv, Z., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113362 · Cited by 31
Alokail, M. S., Al‐Daghri, N. M., Mohammed, A. K., Vanhoutte, P. M., & Alenad, A. M. H. (2014) · Medical Oncology · doi:10.1007/s12032-014-0038-0 · Cited by 31
The role of notch signaling in bone marrow niche
Azizidoost, S., Bavarsad, M. S., Bavarsad, M. S., Shahrabi, S., Jaseb, K., Rahim, F., Shahjahani, M., Saba, F., Ghorbani, M., & Saki, N. (2014) · Hematology · doi:10.1179/1607845414y.0000000167 · Cited by 31
Patel, S., & Rawal, R. (2016) · Tumor Biology · doi:10.1007/s13277-016-5289-2 · Cited by 31
Thyroid Hormone Receptor β Inhibits Self-Renewal Capacity of Breast Cancer Stem Cells
López-Mateo, I., Alonso-Merino, E., Suárez-Cabrera, C., Park, J. W., Cheng, S.-Y., Alemany, S., Paramio, J. M., & Aranda, A. (2020) · Thyroid · doi:10.1089/thy.2019.0175 · Cited by 31
Tumor Milieu Controlled by RB Tumor Suppressor
Kitajima, S., Li, F., & Takahashi, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072450 · Cited by 31
Interleukins as modulators of angiogenesis and anti-angiogenesis in tumors
Ribatti, D. (2018) · Cytokine · doi:10.1016/j.cyto.2018.10.022 · Cited by 30
Pharmacogenomics and cancer stem cells: a changing landscape?
Crea, F., Duhagon, M. A., Farrar, W. L., & Danesi, R. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.03.010 · Cited by 30
Reactive Oxygen Species and Oncoprotein Signaling-A Dangerous Liaison
Chong, S. J. F., Lai, J. X. H., Eu, J. Q., Bellot, G. L., & Pervaiz, S. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7441 · Cited by 30
Xing, Z., Choi, H. S., Kim, J. H., Kim, S., Liu, R., Yun, B., & Lee, D. (2020) · Biomolecules · doi:10.3390/biom10020245 · Cited by 31
Liang, Y., ZHOU, C., Wang, B., Chen, T., Xu, M., Xu, L., & Feng, H. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1962 · Cited by 30
Immunosenescence and cancer vaccines
Provinciali, M. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0665-z · Cited by 30
Avnet, S., Lemma, S., Cortini, M., Di Pompo, G., Perut, F., & Baldini, N. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00305 · Cited by 29
Oh, K., Moon, H., Lee, D., & Yoo, Y.-B. (2015) · Laboratory Animal Research · doi:10.5625/lar.2015.31.4.188 · Cited by 29
Ginseng-derived compounds as potential anticancer agents targeting cancer stem cells
Lee, J., & Lee, H. (2024) · Journal of Ginseng Research · doi:10.1016/j.jgr.2024.03.003 · Cited by 29
Nanomaterials for targeted drug delivery to cancer stem cells
Orza, A. I., Casciano, D. A., & Biris, A. S. (2014) · Drug Metabolism Reviews · doi:10.3109/03602532.2014.900566 · Cited by 30
Choi, B., Chun, E., Kim, S. Y., Kim, M.-Y., Lee, K.-Y., & Kim, S. J. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.09.030 · Cited by 29
Genome-Wide Uncovering of STAT3-Mediated miRNA Expression Profiles in Colorectal Cancer Cell Lines
Zhang, J., Luo, X., Li, H., Deng, L., & Wang, Y. (2014) · BioMed Research International · doi:10.1155/2014/187105 · Cited by 29
Liu, R., Choi, H. S., Kim, S., Kim, J. H., Yun, B., & Lee, D. (2020) · Molecules · doi:10.3390/molecules25194374 · Cited by 28
Jin, S., Nafees, M., Sun, Y., Tan, Y., Yuan, H., Song, D., Guo, Z., & Wang, X. (2020) · Angewandte Chemie · doi:10.1002/ange.202011273 · Cited by 28
Gu, C., Wiest, M. J., Zhang, W., Halder, K., Zurawski, S., Zurawski, G., Joo, H., & Oh, S. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300029 · Cited by 28
Ali, M. L., Noushin, F., Sadia, Q. A., Metu, A. F., Meem, J. N., Chowdhury, M. T., Rasel, M., Suma, K. J., Alim, M. A., Jalil, M. A., et al. (2024) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2024.07.003 · Cited by 28
KOCKAR, F. T., Yildrim, H., Sağkan, R. I., Hagemann, C., Soysal, Y., Anacker, J., Hamza, A. A., Vordermark, D., Flentje, M., & Said, H. M. (2012) · World Journal of Clinical Oncology · doi:10.5306/wjco.v3.i6.82 · Cited by 28
Inflammatory signaling pathways in self-renewing breast cancer stem cells
Hinohara, K., & Gotoh, N. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.08.003 · Cited by 29
Labovsky, V., Martinez, L. M., Davies, K. M., Rivello, H. G., Calcagno, M. D. L., Matas, A., Vallone, V. B. F., Wernicke, A., Choi, H., & Chasseing, N. A. (2014) · Clinical Breast Cancer · doi:10.1016/j.clbc.2014.05.006 · Cited by 28
Immunomodulatory Factors Control the Fate of Melanoma Tumor Initiating Cells
Tuccitto, A., Tazzari, M., Beretta, V., Rini, F., Miranda, C., Greco, A., Santinami, M., Patuzzo, R., Vergani, B., Villa, A., et al. (2016) · Stem Cells · doi:10.1002/stem.2413 · Cited by 27
Tiron, A., Stan, C. S., Luţa, G., Urîtu, C. M., Văcărean-Trandafir, I.-C., Stanciu, G. D., Coroabǎ, A., & Tiron, C. E. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111982 · Cited by 27
Rocha, G. A., Rocha, A. M., Gomes, A. D., de Faria, C. L. L., de Melo, F. F., Batista, S. A., Fernandes, V. C., Almeida, N. B. F., Teixeira, K. N., Brito, K. S., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1533-1 · Cited by 27
The Chemical Potential of Plasma Membrane Cholesterol: Implications for Cell Biology
Ayuyan, A. G., & Cohen, F. S. (2018) · Biophysical Journal · doi:10.1016/j.bpj.2017.12.042 · Cited by 27
Wen, X.-F., Chen, M., Wu, Y., Chen, M.-N., Głogowska, A., Klonisch, T. C., & Zhang, G. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.07.015 · Cited by 27
Notch-Inflammation Networks in Regulation of Breast Cancer Progression
Liubomirski, Y., & Ben‐Baruch, A. (2020) · Cells · doi:10.3390/cells9071576 · Cited by 26
Dynamic regulation of cancer stem cells and clinical challenges
Ni, C., & Huang, J. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0927-7 · Cited by 26
Association between inflammation and cancer stem cell phenotype in breast cancer
Jeong, Y. J., Oh, H. K., Park, S.-M., & Bong, J. J. (2017) · Oncology Letters · doi:10.3892/ol.2017.7607 · Cited by 26
Takamori, S., Toyokawa, G., Shimokawa, M., Kinoshita, F., Kozuma, Y., Matsubara, T., Haratake, N., Akamine, T., Hirai, F., Seto, T., et al. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6385-x · Cited by 26
FA2H Exhibits Tumor Suppressive Roles on Breast Cancers via Cancer Stemness Control
Dai, X., Zhang, S., Cheng, H., Cai, D., Chen, X., & Huang, Z. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01089 · Cited by 26
Ling, H., & Jolicoeur, P. (2012) · Oncogene · doi:10.1038/onc.2012.341 · Cited by 25
Raghunathachar, S. K., Akila, P., Prashant, A., Chandra, B. S., & Nataraj, S. M. (2017) · Europe PMC (PubMed Central) · Cited by 25
Piwarski, S. A., Thompson, C., Chaudhry, A. R., Denvir, J., Primerano, D. A., Fan, J., & Salisbury, T. B. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113845 · Cited by 26
Liu, J.-H., Chen, C., Li, Z.-Y., Zou, Z., Gao, D., Zhang, X., Kuang, X., Sun, Z.-H., Zheng, W., Zhou, P., et al. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112157 · Cited by 25
Shadbad, M. A., Hajiasgharzadeh, K., & Baradaran, B. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118128 · Cited by 24
Huang, Y., Zhang, Q., Guo, Z., Deng, G., Chen, R., & Zheng, Y. (2023) · Cancer Medicine · doi:10.1002/cam4.6095 · Cited by 24
Kim, E. J., Kim, S.-O., Jin, X. J., Ham, S. W., Kim, J., Park, J., Lee, J., Kim, S.-C., & Kim, H. (2014) · Tumor Biology · doi:10.1007/s13277-014-2922-9 · Cited by 24
Role of epigenetic modulation in cancer stem cell fate
Deshmukh, A. P., Binju, M., Arfuso, F., Newsholme, P., & Dharmarajan, A. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.07.003 · Cited by 24
Hypoxia‐induced secretion stimulates breast cancer stem cell regulatory signalling pathways
Jacobsson, H., Harrison, H., Hughes, É., Persson, E., Rhost, S., Fitzpatrick, P., Gustafsson, A., Andersson, D., Gregersson, P., Magnusson, Y., et al. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12500 · Cited by 24
Cancer stem cells in breast and prostate: Fact or fiction?
Sampayo, R. G., & Bissell, M. J. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.03.010 · Cited by 25
Sun, H., Zhou, Z., Dong, Y., Yang, A., & Jiang, J. (2020) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2020.05.005 · Cited by 24
Choi, H. S., Kim, S., Kim, J. H., Ko, Y.-C., & Lee, D. (2020) · Antioxidants · doi:10.3390/antiox9111119 · Cited by 24
COUP-TFII inhibits NFkappaB activation in endocrine-resistant breast cancer cells
Litchfield, L. M., Appana, S. N., Datta, S., & Klinge, C. M. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.10.010 · Cited by 24
Metadata
- Authors
- Sansone, P., Storci, G., Tavolari, S., Guarnieri, T., Giovannini, C., Taffurelli, M., Ceccarelli, C., Santini, D., Paterini, P., Marcu, K. B., Chieco, P., & Bonafè, M.
- Affiliations
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- University of Bologna (IT)
- Corresponding author
- Bonafè, Massimiliano
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2007-12-03
- Volume
- 117
- Issue
- 12
- Pages
- 3988-4002
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2096439
- OpenAlex
- W2114817620
- Cited by
- 779
- References
- 61
- Citations by year
- 2026: 8 · 2025: 18 · 2024: 21 · 2023: 29 · 2022: 27 · 2021: 27 · 2020: 55 · 2019: 40 · 2018: 55 · 2017: 52 · 2016: 45 · 2015: 64 · 2014: 71 · 2013: 70 · 2012: 53
- FWCI
- 15.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Funders
- Fondazione Cassa di Risparmio in Bologna
- Università di Bologna
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- interleukin-6, mammospheres, mammary stem/progenitor cells, breast ductal carcinoma, Notch3, Jagged1, carbonic anhydrase IX, hypoxia tolerance, breast cancer invasion, basal-like breast cancer, MCF-7 cells, autocrine signaling, tumor microenvironment
- MeSH terms
- Carbonic Anhydrase IX, Receptor, Notch3, Serrate-Jagged Proteins, Jagged-1 Protein, Antigens, Neoplasm, Breast Neoplasms, Calcium-Binding Proteins, Carbonic Anhydrases, Female, Humans, Membrane Proteins, Neoplasm Invasiveness, Neoplasm Proteins, RNA, Messenger, RNA, Neoplasm, Stem Cells, Cell Hypoxia, Interleukin-6, Up-Regulation, Gene Expression Regulation, Neoplastic, Spheroids, Cellular, Autocrine Communication, Intercellular Signaling Peptides and Proteins, Mammary Glands, Human, Carcinoma, Ductal, Cell Line, Tumor, Receptors, Notch
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.